Shadi Al-Bahri1, Tannous K Fakhry2, John Paul Gonzalvo2, Michel M Murr2. 1. Department of Surgery, University of South Florida-Health, Tampa General Hospital, Tampa, FL, USA. shadialbahri@gmail.com. 2. Department of Surgery, University of South Florida-Health, Tampa General Hospital, Tampa, FL, USA.
Abstract
BACKGROUND: Obesity is a relative contraindication to organ transplantation. Preliminary reports suggest that bariatric surgery may be used as a bridge to transplantation in patients who are not eligible for transplantation because of morbid obesity. SETTING: The Bariatric Center at Tampa General Hospital, University of South Florida, Tampa, Florida. METHODS: We reviewed the outcomes of 16 consecutive patients on hemodialysis for end-stage renal disease (ESRD) who underwent bariatric surgery from 1998 to 2016. Demographics, comorbidities, weight loss, as well as transplant status were reported. Data is mean ± SD. RESULTS: Six men and ten women aged 43-66 years (median = 54 years) underwent laparoscopic Roux-en-Y gastric bypass (LRYGB, n = 12), laparoscopic adjustable gastric banding (LAGB, n = 3), or laparoscopic sleeve gastrectomy (LSG, n = 1). Preoperative BMI was 48 ± 8 kg/m2. Follow-up to date was 1-10 years (median = 2.8 years); postoperative BMI was 31 ± 7 kg/m2; %EBWL was 62 ± 24. Four patients underwent renal transplantation (25%) between 2.5-5 years after bariatric surgery. Five patients are currently listed for transplantation. Five patients were not listed for transplantation due to persistent comorbidities; two of these patients died as a consequence of their comorbidities (12.5%) more than 1 year after bariatric surgery. Two patients were lost to follow-up (12.5%). CONCLUSION: Bariatric surgery is effective in patients with ESRD and improves access to renal transplantation. Bariatric surgery offers a safe approach to weight loss and improvement in comorbidities in the majority of patients. Referrals of transplant candidates with obesity for bariatric surgery should be considered early in the course of ESRD.
BACKGROUND:Obesity is a relative contraindication to organ transplantation. Preliminary reports suggest that bariatric surgery may be used as a bridge to transplantation in patients who are not eligible for transplantation because of morbid obesity. SETTING: The Bariatric Center at Tampa General Hospital, University of South Florida, Tampa, Florida. METHODS: We reviewed the outcomes of 16 consecutive patients on hemodialysis for end-stage renal disease (ESRD) who underwent bariatric surgery from 1998 to 2016. Demographics, comorbidities, weight loss, as well as transplant status were reported. Data is mean ± SD. RESULTS: Six men and ten women aged 43-66 years (median = 54 years) underwent laparoscopic Roux-en-Y gastric bypass (LRYGB, n = 12), laparoscopic adjustable gastric banding (LAGB, n = 3), or laparoscopic sleeve gastrectomy (LSG, n = 1). Preoperative BMI was 48 ± 8 kg/m2. Follow-up to date was 1-10 years (median = 2.8 years); postoperative BMI was 31 ± 7 kg/m2; %EBWL was 62 ± 24. Four patients underwent renal transplantation (25%) between 2.5-5 years after bariatric surgery. Five patients are currently listed for transplantation. Five patients were not listed for transplantation due to persistent comorbidities; two of these patients died as a consequence of their comorbidities (12.5%) more than 1 year after bariatric surgery. Two patients were lost to follow-up (12.5%). CONCLUSION: Bariatric surgery is effective in patients with ESRD and improves access to renal transplantation. Bariatric surgery offers a safe approach to weight loss and improvement in comorbidities in the majority of patients. Referrals of transplant candidates with obesity for bariatric surgery should be considered early in the course of ESRD.
Entities:
Keywords:
Dialysis; Metabolic surgery; Morbid obesity; Organ transplantation; Renal allograft; Renal failure; Safety; Survival; UNOS
Authors: Kian A Modanlou; Umadevi Muthyala; Huiling Xiao; Mark A Schnitzler; Paolo R Salvalaggio; Daniel C Brennan; Kevin C Abbott; Ralph J Graff; Krista L Lentine Journal: Transplantation Date: 2009-04-27 Impact factor: 4.939
Authors: J L Gore; P T Pham; G M Danovitch; A H Wilkinson; J T Rosenthal; G S Lipshutz; J S Singer Journal: Am J Transplant Date: 2006-02 Impact factor: 8.086
Authors: Dorry L Segev; Christopher E Simpkins; Richard E Thompson; Jayme E Locke; Daniel S Warren; Robert A Montgomery Journal: J Am Soc Nephrol Date: 2007-12-19 Impact factor: 10.121
Authors: Christopher W Glanton; Tzu-Cheg Kao; David Cruess; Lawrence Y C Agodoa; Kevin C Abbott Journal: Kidney Int Date: 2003-02 Impact factor: 10.612
Authors: Babak J Orandi; Joshua W Purvis; Robert M Cannon; A Blair Smith; Cora E Lewis; Norah A Terrault; Jayme E Locke Journal: Am J Surg Date: 2020-06-13 Impact factor: 2.565
Authors: Kyle H Sheetz; Kenneth J Woodside; Vahakn B Shahinian; Justin B Dimick; John R Montgomery; Seth A Waits Journal: Clin J Am Soc Nephrol Date: 2019-07-25 Impact factor: 8.237
Authors: Janey S A Pratt; Sebastian S Roque; Ruben Valera; Kathryn S Czepiel; Deborah D Tsao; Fatima Cody Stanford Journal: Semin Pediatr Surg Date: 2020-01-20 Impact factor: 2.754
Authors: Loubna Outmani; Hendrikus J A N Kimenai; Joke I Roodnat; Marjolijn Leeman; Ulas L Biter; René A Klaassen; Jan N M IJzermans; Robert C Minnee Journal: Clin Transplant Date: 2021-01-09 Impact factor: 2.863